Abstract
The influence of the high genetic variability of hepatitis B virus (HBV) on the sensitivity of serological assays has received little attention so far. A major source of variability is related to viral genotypes and subgenotypes. Their possible influence on diagnosis and prophylaxis is poorly known and has mostly been evaluated for genotypes A, B, C and D. Robust data showing the detection efficiency of HBsAg from genotype F is lacking. This study examined the effect of virus-like particles containing HBsAg from genotypes A and F (particularly, F1b and F4) produced in Pichia pastoris in relation to the anti-HBs antibodies used in the immunoassays for in vitro diagnosis and compared it with that exerted by the G145R S-escape mutant. The results showed that HBsAg detection rates for subgenotypes F1b and F4 differed significantly from those obtained for genotype A and that subgenotype F1b had a major impact on the sensitivity of the immunoassays tested. Prediction of the tertiary structure of subgenotypes F1b and F4 revealed changes inside and outside the major hydrophilic region (aa 101-160) of the HBsAg compared to genotype A and the G145R variant. A phosphorylation site (target for protein kinase C) produced by the G145R substitution might prevent recognition by anti-HBs antibodies. In conclusion, the use of different genotypes or variants for diagnosis could improve the rate of detection of HBV infection. The incorporation of a genotype-F-derived HBsAg vaccine in areas where this genotype is endemic should be evaluated, since this might also affect vaccination efficacy.
Similar content being viewed by others
References
WHO (2017) Hepatitis B. World Health Organization Fact sheet N°204. http://www.who.int/mediacentre/factsheets/fs204/en. Accessed 9 Apr 2018
Kramvis A (2014) Genotypes and genetic variability of hepatitis B virus. Intervirology 57:141–150. https://doi.org/10.1159/000360947
Lin CL, Kao JH (2017) Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol 31:249–255. https://doi.org/10.1016/j.bpg.2017.04.010
Croagh CMN, Desmond PV, Bell SJ (2015) Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol 7(3):289–303. https://doi.org/10.4254/wjh.v7.i3.289
Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F (2014) Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol 20(23):7152–7168
Alvarado-Mora MV, Rebello Pinho JR (2013) Distribution of HBV genotypes in Latin America. Antivir Ther 18:459–465. https://doi.org/10.3851/IMP2599
Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J (2002) Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in Western patients. Gastroenterology 123:1848–1856
Livingston SE, Simonetti J, McMahn BJ, Bulkow LR, Hurlburt KJ, Homan CE, Snowball MM, Cagle HH, Williams JL, Chulanov VP (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195:5–11
Marciano S, Galdamo OA, Gadano AC (2013) HBV genotype F: Natural history and treatment. Antivir Ther 18:485–488. https://doi.org/10.3851/IMP2604
Cassidy A, Mossman S, De Ridder M, Leroux-Roels G (2011) Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity. Expert Rev Vaccines 10(12):1709–1715. https://doi.org/10.1586/erv.11.151
Tacke F, Amini-Bavil-Olyaee S, Heim A, Luedde T, Manns MP, Trautwein C (2007) Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol 38:353–357
O’Halloran JA, De Gascun CF, Dunford L, Carr MJ, Connell J, Howard R, Hall WW, Lambert JS (2011) Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection. J Clin Virol 52:151–154. https://doi.org/10.1016/j.jcv.2011.06.020
Xiao A, Zhou X, Zhou L, Zhang Y (2006) Improvement of cell viability and hirudin production by ascorbic acid in Pichia pastoris fermentation. Appl Microbiol Biotechnol 72:837–844
Celik E, Calık P, Oliver S (2009) Fed-batch methanol feeding strategy for recombinant protein production by Pichia pastoris in the presence of co-substrate sorbitol. Yeast 26:473–484
Bhatacharya P, Pandey G, Mukherjee KJ (2007) Production and purification of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) from high cell density cultures of Pichia pastoris. Bioprocess Biosyst Eng 30:305–312
Noseda DG, Recúpero MN, Blasco M, Ortiz GE, Galvagno MA (2013) Cloning, expression and optimized production in a bioreactor of bovine chymosin B in Pichia (Komagataella) pastoris under AOXI promoter. Protein Expr Purif 92:235–244. https://doi.org/10.1016/j.pep.2013.08.018
Noseda DG, Blasco M, Recúpero MN, Galvagno MA (2014) Bioprocess and downstream optimization of recombinant bovine chymosin B in Pichia (Komagataella) pastoris under methanol-inducible AOXI promoter. Protein Expr Purif 104:85–91. https://doi.org/10.1016/j.pep.2014.09.014
Bardiya N (2006) Expression in and purification of hepatitis B surface antigen (S-protein) from methylotrophic yeast Pichia pastoris. Anaerobe 12:194–203
Gurramkonda C, Zahid M, Nemani SK, Adnan A, Gudi SK, Ebensen T, Lünsdorf H, Guzmán CA, Rinas U (2013) Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. J Chromatogr B Analyt Technol Biomed Life Sci 940:104–111. https://doi.org/10.1016/j.jchromb.2013.09.030
Peyret H (2015) A protocol for the gentle purification of virus like particles produced in plants. J Virol Methods 225:59–63. https://doi.org/10.1016/j.jviromet.2015.09.005
Drozdetskiy A, Cole C, Procter J, Barton GJ (2015) JPred4: a protein secondary structure prediction server. Nucleic Acids Res 43(W1):W389–W394. https://doi.org/10.1093/nar/gkv332
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (2015) The I-TASSER Suite: Protein structure and function prediction. Nat Methods 12:7–8. https://doi.org/10.1038/nmeth.3213
Laskowski RA, MacArthur MW, Moss D, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291
Studer G, Biasini M, Schwede T (2014) Assessing the local structural quality of transmembrane protein models using statistical potentials (QMEANBrane). Bioinformatics 30(17):i505–i511. https://doi.org/10.1093/bioinformatics/btu457
Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:W407–W410
Xu D, Zhang Y (2011) Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 101:2525–2534. https://doi.org/10.1016/j.bpj.2011.10.024
Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL (2012) OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res 40(Database issue):D370–D376. https://doi.org/10.1093/nar/gkr703
Holm L, Rosenström P (2010) Dali server: conservation mapping in 3D. Nucleic Acids Res 38:W545–W549. https://doi.org/10.1093/nar/gkq366
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605–1612
Milhiet P-E, Dosset P, Godefroy C, Le Grimellec C, Guigner J-M, Larquet E, Ronzon F, Manin C (2011) Nanoscale topography of hepatitis B antigen particles by atomic force microscopy. Biochimie 93:254–259. https://doi.org/10.1016/j.biochi.2010.09.018
Lündsorf H, Gurramkonda C, Adnan A, Khanna N, Rinas U (2001) Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen. Microb Cell Fact 10:48
Wampler DE, Lehman ED, Boger J, McAleer WJ, Scolnick EM (1985) Multiple chemical forms of hepatitis B surface antigen produced in yeast. Proc Natl Acad Sci USA 82:6830–6834
Zhao Q, Wang Y, Freed D, Fu T-M, Gimenez JA, Sitrin RD, Washabaugh MW (2006) Maturation of recombinant hepatitis B virus surface antigen particles. Hum Vaccin 2(4):174–180
Zahid M, Lündsorf H, Rinas U (2015) Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing. Vaccine 33:3739–3745. https://doi.org/10.1016/j.vaccine.2015.05.066
Ottone S, Nguyen X, Bazin J, Bérard C, Jimenez S, Letourneur O (2007) Expression of hepatitis B surface antigen major subtypes in Pichia pastoris and purification for in vitro diagnosis. Protein Expr Purif 56:177–188
Gilbert RJ, Beales L, Blond D, Simon MN, Lin BY, Chisari FV, Stuart DI, Rowlands DJ (2005) Hepatitis B small surface antigen particles are octahedral. Proc Natl Acad Sci USA 102(41):14783–14788
Olinger CM, Weber B, Otegbayo JA, Ammerlaan W, van der Taelem-Brulé N, Muller CP (2007) Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene. Med Microbiol Immunol 196:247–252
Araujo NM, Vianna COA, Morales MTB, Gomes SA (2009) Expression of hepatitis B virus surface antigen (HBsAg) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBsAg detection. Braz J Infect Dis 13:266–271
Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunet H-P, Prince A (2010) Performance evaluation of70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98:403–414. https://doi.org/10.1111/j.1423-0410.2009.01272.x
Hadiji-Abbes N, Mihoubi W, Martin M, Karakasyan-Dia C, Frikha F, Gergely C, Jouenne T, Gargouri A, Mokdad-Gargouri R (2015) Characterization of C69R variant HBsAg: effect on bindingto anti-HBs and the structure of virus-like particles. Arch Virol 160:2427–2433. https://doi.org/10.1007/s00705-015-2515-y
Acknowledgements
DGN, ADN, PDG, CSC and MLC are staff members of CONICET. MJL thanks CONICET for her doctoral scholarship.
Funding
This study was funded by the University of Buenos Aires (Grant UBACyT 20020130200222BA) and by the Agencia Nacional de Promoción Científica y Técnica (ANPCyT, Grant PICT 201-0206).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest regarding funding or other aspects of this manuscript.
Ethical approval
The study was approved by the institutional review committee at Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires (Ref. EXP- UBA N” 0051009/2016).
Additional information
Handling Editor: Zhongjie Shi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Limeres, M.J., Gomez, E.R., Noseda, D.G. et al. Impact of hepatitis B virus genotype F on in vitro diagnosis: detection efficiency of HBsAg from Amerindian subgenotypes F1b and F4. Arch Virol 164, 2297–2307 (2019). https://doi.org/10.1007/s00705-019-04332-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-019-04332-8